Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21945262 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes
Condition: Herpes Simplex Type II
Interventions: Drug: HerpV and QS-21;   Drug: Placebo

Indicates status has not been verified in more than two years